Cargando…
The Influence of a KDT501, a Novel Isohumulone, on Adipocyte Function in Humans
OBJECTIVE: In a phase II clinical trial in nine obese, insulin-resistant humans, we observed that treatment with KDT501, a novel isohumulone drug, increased total and high-molecular weight (HMW) adiponectin in plasma. The objective was to determine whether KDT501 increased adiponectin secretion from...
Autores principales: | Finlin, Brian S., Zhu, Beibei, Kok, Bernard P., Godio, Cristina, Westgate, Philip M., Grayson, Neile, Sims, Robert, Bland, Jeffrey S., Saez, Enrique, Kern, Philip A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5626816/ https://www.ncbi.nlm.nih.gov/pubmed/29033896 http://dx.doi.org/10.3389/fendo.2017.00255 |
Ejemplares similares
-
Effects of KDT501 on Metabolic Parameters in Insulin-Resistant Prediabetic Humans
por: Kern, Philip A., et al.
Publicado: (2017) -
KDT501, a Derivative from Hops, Normalizes Glucose Metabolism and Body Weight in Rodent Models of Diabetes
por: Konda, Veera R., et al.
Publicado: (2014) -
Improved β-cell function leads to improved glucose tolerance in a transgenic mouse expressing lipoprotein lipase in adipocytes
por: Memetimin, Hasiyet, et al.
Publicado: (2022) -
OR01-4 Mast Cells and Human Adipose Beiging: Mast Cells Are Recruited to Subcutaneous White Adipose and Degranulate in Response to Cold
por: Kern, Philip, et al.
Publicado: (2019) -
Intestinal bitter taste receptor activation alters hormone secretion and imparts metabolic benefits
por: Kok, Bernard P., et al.
Publicado: (2018)